Keyphrases
Cryptococcosis
74%
Histoplasmosis
55%
Invasive Fungal Infection
51%
Cryptococcal Infection
46%
People Living with HIV (PLHIV)
40%
AIDS/HIV
37%
Infectious Diseases
33%
Antifungal Therapy
32%
Guatemala
28%
Confidence Interval
28%
Candidemia
27%
Liposomal Amphotericin B
26%
Risk Factors
25%
Mycoses
25%
Fungal Infection
24%
Candida Bloodstream Infection
23%
Itraconazole
23%
Cryptococcal Meningitis
22%
Endemic Mycoses
21%
International Guidelines
20%
Invasive Candidiasis
19%
Rezafungin
19%
Ibrexafungerp
19%
COVID-19
19%
Fluconazole Resistance
19%
Clinical Prediction Model
19%
Medical Mycology
19%
United States
18%
Antiretroviral Therapy
18%
Retrospective Cohort Study
18%
Fluconazole
17%
Azoles
16%
Voriconazole
16%
Amphotericin B
16%
Invasive Fungal Disease
16%
Infectious Diseases Consultation
15%
Immunocompromised Patients
15%
Adjusted Odds Ratio
15%
Solid Organ Transplant
14%
Hazard Ratio
14%
Epidemiology
14%
Human Immunodeficiency Virus Negative
14%
Single High Dose
14%
Candida
13%
Histoplasma Capsulatum
13%
In Vitro Activity
13%
High Mortality
13%
Infectious Disease Physician
13%
Disseminated Histoplasmosis
13%
Infectious Diseases Society of America
13%
Medicine and Dentistry
Infection
100%
Human Immunodeficiency Virus
93%
Cryptococcosis
72%
Disease
47%
Mycosis
42%
Histoplasmosis
37%
Systemic Mycosis
37%
Cohort Analysis
26%
Amphotericin B
26%
Cryptococcal Meningitis
23%
Bloodstream Infection
22%
Antifungal Therapy
21%
Dimorphic Fungal Infection
20%
Cooperation
19%
Candidemia
19%
Medical Mycology
19%
Central Nervous System
19%
Retrospective Cohort Study
17%
Consultation
15%
Antiretroviral Therapy
15%
Hazard Ratio
15%
Clinician
14%
COVID-19
13%
Social Media
12%
Prevalence
12%
Odds Ratio
11%
Fluconazole
11%
Flucytosine
11%
Cohort Effect
10%
Blastomycosis
9%
Pyrrole Derivative
9%
T Cell
9%
Immunomodulation
9%
Silo-Filler's Disease
9%
Immunocompromised Patient
8%
Disseminated Disease
8%
Coccidioidomycosis
8%
Patient Population
8%
Proportional Hazards Model
8%
Outpatient
7%
Clinical Decision Making
7%
Symptom
7%
In Vitro
7%
Drug Megadose
7%
Transplantation
7%
Opportunistic Infection
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Lumbar Puncture
6%
Antimicrobial Therapy
6%
Metabolic Syndrome
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
59%
HIV
56%
Histoplasmosis
43%
Amphotericin B
34%
Systemic Mycosis
33%
Candida
30%
Mycosis
30%
Disease
30%
Bloodstream Infection
25%
Fluconazole
24%
Antifungal Agent
24%
Itraconazole
23%
Cryptococcosis
22%
Cryptococcal Meningitis
22%
Candidemia
21%
Invasive Candidiasis
19%
Ibrexafungerp
19%
Rezafungin
19%
Dimorphic Fungal Infection
19%
Cohort Study
16%
Antifungal Therapy
16%
Voriconazole
16%
Ajellomyces capsulatus
13%
Isavuconazole
13%
Olorofim
12%
Bioavailability
12%
Prevalence
12%
Echinocandin
9%
Clinical Trial
8%
Pyrrole Derivative
8%
Opportunistic Infection
7%
Drug Resistance
7%
All Cause Mortality
7%
SARS Coronavirus
7%
Candidiasis
6%
Pyrrole
6%
Adverse Event
6%
Coronavirinae
6%
Antimicrobial Therapy
6%
Disease Marker
6%
Metabolic Syndrome X
6%
Viremia
6%
Isavuconazonium
6%
Mucormycosis
6%
Inflammatory Bowel Disease
6%
Biological Marker
6%
Aureobasidin A
6%
Nikkomycin Z
6%
Atypical Mycobacteriosis
6%
Echinocandins
6%